Sarepta Therapeutics | 流动负债

Current Liabilities 更改 日
Acadia Pharmaceuticals USD 330.6M 76.34M 2024-03
Alnylam Pharmaceuticals USD 941.71M 26.08M 2024-03
Amgen USD 19.71B 1.32B 2024-03
Avrobio USD 7.56M 4.1M 2023-09
Biogen USD 3.22B 211.5M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Eli Lilly USD 18.6B 3.4B 2024-03
Gilead Sciences USD 13.02B 1.74B 2024-03
Incyte USD 1.4B 156.07M 2024-03
Insmed USD 420.86M 195.23M 2024-03
Ionis Pharmaceuticals USD 327.65M 120.44M 2024-03
Moderna USD 2.38B 635M 2024-03
Neurocrine Biosciences USD 712.9M 21.3M 2024-03
Pfizer USD 40.5B 9.36B 2024-03
PTC Therapeutics USD 574.55M 28.55M 2024-03
Regeneron Pharmaceuticals USD 3.58B 823.3M 2024-03
Roche Holding CHF 26.21B 1.03B 2023-06
Sarepta Therapeutics USD 608.71M 157.97M 2024-03
Ultragenyx Pharmaceutical USD 245.58M 8.4M 2024-03
Vertex Pharmaceuticals USD 3.8B 196.5M 2024-03



Sarepta Therapeutics 流动负债 - 当前值，历史数据，预测，统计，图表和经济日历 - Jun 2024.